These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1394814)

  • 1. Intravesical combination chemotherapy with mitomycin C and doxorubicin for superficial bladder cancer: a randomized trial of maintenance versus no maintenance following a complete response.
    Fukui I; Kihara K; Sekine H; Tachibana Y; Kawai T; Ishiwata D; Oshima H
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S37-40. PubMed ID: 1394814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical mitomycin C and doxorubicin sequential therapy for carcinoma in situ of the bladder: a longer followup result.
    Sekine H; Fukui I; Yamada T; Ohwada F; Yokokawa M; Ohshima H
    J Urol; 1994 Jan; 151(1):27-30. PubMed ID: 8254827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical combination chemotherapy with mitomycin C and doxorubicin for carcinoma in situ of the bladder.
    Fukui I; Sekine H; Kihara K; Yamada T; Takeuchi S; Yokokawa M; Kawai T; Hosoda K; Ohwada F; Suzuki S
    J Urol; 1989 Mar; 141(3):531-4. PubMed ID: 2493099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological grading of carcinoma in situ of the bladder: its clinical significance in patients who underwent intravesical mitomycin C and doxorubicin sequential therapy.
    Sekine H; Fukui I; Yamada T; Yamada T; Kojima S; Ohshima H
    J Urol; 1996 Jan; 155(1):94-8; discussion 98-9. PubMed ID: 7490908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study.
    Boccardo F; Cannata D; Rubagotti A; Guarneri D; Decensi A; Canobbio L; Curotto A; Martorana G; Pegoraro C; Selvaggi F
    J Clin Oncol; 1994 Jan; 12(1):7-13. PubMed ID: 8270987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical mitomycin C for carcinoma in situ of the urinary bladder.
    Hellsten S; Månsson W; Henrikson H; Idwall I; Lindholm K; Mikulowski P; Mårtensson S; Oldbring J
    Scand J Urol Nephrol; 1990; 24(1):35-8. PubMed ID: 2108491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder cancer.
    Isaka S; Okano T; Abe K; Shimazaki J
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S41-4. PubMed ID: 1394815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin plus mitomycin C regimen in the prophylactic treatment of superficial bladder tumors.
    Ferraris V
    Cancer; 1988 Sep; 62(6):1055-60. PubMed ID: 3136907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of intravesical chemotherapy on superficial urinary bladder cancer].
    Moriyama M; Kubota Y; Miura T; Shuin T; Noguchi S
    Hinyokika Kiyo; 1983 Mar; 29(3):351-5. PubMed ID: 6203382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer.
    Chen CH; Yang HJ; Shun CT; Huang CY; Huang KH; Yu HJ; Pu YS
    Urol Oncol; 2012; 30(4):421-7. PubMed ID: 20870427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intravesical instillation of epirubicin hydrochloride in superficial bladder tumor--prophylactic and therapeutic instillation for carcinoma in situ].
    Shichiri Y; Kanba T; Yoshida S; Arai Y
    Hinyokika Kiyo; 1995 May; 41(5):359-64. PubMed ID: 7598036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
    Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
    Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients.
    Huland H; Klöppel G; Feddersen I; Otto U; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F; Huland E
    J Urol; 1990 Jul; 144(1):68-71; discussion 71-2. PubMed ID: 2113590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sequential instillation therapy with mitomycin-C and adriamycin in superficial bladder tumor with special reference to fate of 43 patients achieving complete response].
    Fukui I; Sekine H; Kihara K; Yamada T; Kawai T; Washizuka M; Ishiwata D; Oka K; Hosoda K; Ikegami S
    Nihon Hinyokika Gakkai Zasshi; 1987 Sep; 78(9):1539-44. PubMed ID: 3127621
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors.
    Fukui I; Sekine H; Kihara K; Yamada T; Kawai T; Washizuka M; Ishiwata D; Oka K; Hosoda K; Ikegami S
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S52-5. PubMed ID: 3117399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic chemotherapy for primary and recurrent superficial bladder cancer: preliminary results. The Hokkaido University Bladder Cancer Collaborating Group.
    Togashi M; Shinohara N; Toyota K; Koyanagi T; Maru A; Fujieda J; Kawakura K; Nishida T; Ohashi N
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S21-5. PubMed ID: 1394811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of intravesical instillation therapy of superficial bladder tumor--combination therapy of mitomycin C, adriamycin, peplomycin and cytosine arabinoside].
    Kinoshita N; Tochigi H; Yanagawa M; Yamakawa K; Sakurai M; Hioki T; Kawamura J
    Hinyokika Kiyo; 1990 Mar; 36(3):257-63. PubMed ID: 1693807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of maintenance treatment of mitomycin C or alternating mitomycin C and bacillus Calmette-Guérin instillation therapy of patients with carcinoma in situ of the bladder: a subgroup analysis of the prospective FinnBladder 2 study with a 17-year follow-up.
    Järvinen R; Kaasinen E; Rintala E; Group TF
    Scand J Urol Nephrol; 2012 Dec; 46(6):411-7. PubMed ID: 22746387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylactic effect of UFT in combination with intravesical chemotherapy on the recurrence of superficial bladder tumor].
    Yoshida O; Kakehi Y; Nishio Y; Tomoyoshi T; Konami T; Usui T; Igawa M; Takenaka I; Fujita K
    Hinyokika Kiyo; 1992 Dec; 38(12):1437-43. PubMed ID: 1288238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.